Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Metrics to compare | DIVI | Peers Peers - average of corresponding metrics from companies closely matching DIVI: SYNGENE, DCAL, SUVEN, AKUMS, MOREPENLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDIVIPeersSector |
---|---|---|---|---|
P/E Ratio | 86.0x | 33.1x | −0.7x | |
PEG Ratio | 7.09 | 0.14 | 0.00 | |
Price/Book | 11.5x | 4.5x | 2.6x | |
Price / LTM Sales | 18.3x | 3.1x | 3.2x | |
Upside (Analyst Target) | −19.7% | 1.6% | 43.9% | |
Fair Value Upside | Unlock | −14.6% | 6.5% | Unlock |